...
首页> 外文期刊>The journal of asthma >Asthma control test is correlated to FEV1 and nitric oxide in Greek asthmatic patients: influence of treatment.
【24h】

Asthma control test is correlated to FEV1 and nitric oxide in Greek asthmatic patients: influence of treatment.

机译:哮喘控制测试与希腊哮喘患者的FEV1和一氧化氮相关:治疗的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Asthma is a common chronic disease affecting patients' health status and quality of life. Although recent guidelines focus on asthma control, asthma remains poorly controlled in many patients even under specialist care. Asthma Control Test (ACT) is a short, simple, patient-based tool that provides consistent assessment of asthma. OBJECTIVE: The aim of this study was to estimate the relationship of ACT with objective measures of lung function and inflammation such as forced expiratory volume in 1st second (FEV(1)) and exhaled nitric oxide (FeNO) in outpatients admitted for initial diagnosis of asthma and at follow-up. METHODS: One hundred and sixty (104 women and 56 men, mean age 39.7 +/- 16.6 years) asthmatic patients with newly diagnosed asthma were included in the study. Patients completed the ACT questionnaire and underwent a detailed clinical examination, FeNO measurement, and prebronchodilator spirometry before (visit 1) and 4-12 weeks after initiation of treatment (visit 2). RESULTS: At visit 1, the mean ACT score was 21.27 +/- 3.74. According to ACT score, 37 patients (23.1%) were completely controlled, 85 patients (53.1%) were partly controlled, and 38 patients (23.8%) were uncontrolled. Patients with uncontrolled asthma had statistically higher FeNO values than patients with partly controlled (p = .038) and completely controlled asthma (p = .016). ACT score was found to have a positive correlation with prebronchodilator %FEV(1) (r = 0.177, p = .025) and negative correlation with FeNO ( r = -0.211, p = .007). At visit 2, the mean ACT score was 23.00 +/- 2.19. The change in ACT score between the two visits was significantly correlated to changes in FEV(1) (r = 0.538, p < .001) and in FeNO (r = -0.466, p < .001). Patients treated with inhaled corticosteroids (ICSs) showed significant improvement in FEV(1) and in ACT score and a decrease in FeNO compared with patients without ICS treatment. CONCLUSION: Although FEV(1) remains the main objective parameter for evaluating asthma, ACT score was found to reflect lung function and inflammation in a Greek asthmatic population.
机译:背景:哮喘是一种常见的慢性疾病,会影响患者的健康状况和生活质量。尽管最近的指南将重点放在哮喘的控制上,但是即使在专科医生的照护下,许多患者的哮喘控制仍然很差。哮喘控制测试(ACT)是一种基于患者的简短,简单的工具,可对哮喘进行一致的评估。目的:本研究的目的是评估首次诊断为门诊的门诊患者,ACT与肺功能和炎症的客观测量之间的关系,例如第一秒的强制呼气量(FEV(1))和呼出气一氧化氮(FeNO)。哮喘和随访。方法:本研究纳入了160名(104名女性和56名男性,平均年龄39.7 +/- 16.6岁)患有哮喘的新诊断哮喘患者。患者完成ACT问卷并在开始治疗前(访问1)和治疗开始后4-12周(访问2)进行了详细的临床检查,FeNO测量和支气管扩张剂肺活量测定。结果:第一次访问时,平均ACT评分为21.27 +/- 3.74。根据ACT评分,完全控制37例(23.1%),部分控制85例(53.1%),未控制38例(23.8%)。与未完全控制的哮喘(p = .038)和完全控制的哮喘(p = .016)的患者相比,未控制哮喘的患者的FeNO值在统计学上较高。发现ACT评分与支气管扩张剂前期FEV(1)正相关(r = 0.177,p = .025),与FeNO呈负相关(r = -0.211,p = .007)。在第2次造访时,平均ACT分数为23.00 +/- 2.19。两次访视之间的ACT评分变化与FEV(1)(r = 0.538,p <.001)和FeNO(r = -0.466,p <.001)的变化显着相关。与未接受ICS治疗的患者相比,接受吸入糖皮质激素(ICSs)治疗的患者的FEV(1)和ACT评分显着改善,FeNO降低。结论:尽管FEV(1)仍然是评估哮喘的主要客观参数,但发现ACT评分反映了希腊哮喘人群的肺功能和炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号